Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Handb Exp Pharmacol. 2022;271:315–350. doi: 10.1007/164_2021_434

Table 2.

Evidence that KOR activation contributes to stress-induced reinstatement of opioid seeking behavior in preclinical models

KOR ligand Species Sex Drug of abuse/protocol Stressor/pain Main outcome Reference Pain component
Nor-BNI Sprague Dawley rats Male Heroin IVSA and stress-induced reinstatement Yohimbine (YOH) KOR blockade reduced reinstatement (Zhou et al. 2013) No
Nor-BNI Sprague Dawley rats Male Heroin IVSA and stress-induced reinstatement Food deprivation KOR blockade reduced reinstatement (Sedki et al. 2015) No
Nor-BNI Mouse (C57B1/6) Male Morphine CPP and drug-prime reinstatement Incisional postsurgical pain model KOR blockade enhanced drug-primed reinstatement (Nwaneshiudu et al. 2020) Yes
LY2456302 Sprague Dawley rats Male Oxycodone IVSA and cue-induced reinstatement None KOR blockade had no effect on reinstatement (Bossert et al. 2019) No
CJ-15208 (Cyclo[Pro-Sar-Phe-D-Phe]) or Nor-BNI Mouse (C57B1/6) Male Morphine CPP and stress-induced reinstatement Forced swim stress Both drug interventions prevented reinstatement (Brice-Tutt et al. 2020; Ferracane et al. 2020) No
Buprenorphine + naltrexone Sprague Dawley rats Male Morphine CPP and drug-prime reinstatement None The combination blocked drug-primed reinstatement (Cordery et al. 2014) No
Dezocine (partial MOR agonist, KOR antagonist) or buprenorphine Sprague Dawley rats Male Morphine CPP and drug-prime reinstatement None Both drug interventions prevented reinstatement (Wu et al. 2019) No
Nor-BNI Sprague Dawley rats Male Morphine CPP and drug-prime reinstatement None KOR blockade did not alter drug-primed reinstatement (He et al. 2019) No